4
Changes in Ownership
Aclaris Therapeutics, Inc. Filed Acc 0001209191-20-016073
Chief Legal Officer gave up 4,779 shares (to pay taxes)
- Chief Legal Officer acquired 17,175 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Ali-Jackson Kamil Chief Legal Officer | 2020-03-02 | Option exercise | +17,175 | 103,978 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2020-03-02 | Shares withheld for taxes | −4,779 | $1.26 | $6,022 | 99,199 | D |
| Derivatives | |||||||
| Ali-Jackson Kamil Chief Legal Officer | 2020-03-02 | Option exercise · Restricted stock units | −17,175 | 51,525 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2020-03-02 | Grant or award · Employee Stock Option (Right to Buy) | +92,928 | 92,928 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2020-03-02 | Grant or award · Restricted stock units | +66,377 | 66,377 | D | ||
| Ali-Jackson Kamil Chief Legal Officer | 2020-03-02 | Grant or award · Restricted stock units | +26,551 | 26,551 | D | ||
Loading xslF345X03/doc4.xml…